Search

everythinglearnresearchcommunity

for

Search:↓

Higher IL-17A levels indicate more severe alopecia areata.

Specialist nurses play a crucial role in managing lupus and empowering patients.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Dermoscopy helps diagnose and manage alopecia areata by showing specific hair changes.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Patients with Discoid Lupus Erythematosus have lower vitamin D and antioxidant levels and higher oxidative stress.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.